Allegrow receives TSSSU 2023/24 support!

· Milestone,News

We are thrilled to announce that Allegrow is one of the Technology Start-up Support Scheme for Universities (TSSSU) awardees 2023/24.

The scheme aims to provide funding and other support to technology start-ups emerging from local universities in Hong Kong. As a young biotech start-up focusing on platform R&D, the support from TSSSU enables Allegrow to further translate our research findings into commercial products.

With this support, we plan to launch our first MVP, Aim-Tconv by 2024, offering cell therapy researchers and clinicians a cost-efficient solution to produce conventional T-cell.

broken image

Previous
Next
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save